SciFluor Life Sciences Obtains $30,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a0841378-c8e4-4b6e-8401-5a02d9572c53
Date
4/22/2015
Company Name
SciFluor Life Sciences
Mailing Address
300 Technology Square Cambridge, MA 02139 USA
Company Description
The company’s late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor’s technology enables end-stage or any-stage fluorination of a wide variety of organic compounds. Our technology and our library of fluorinated analogs are protected by an extensive intellectual property portfolio.
Website
http://www.scifluor.com
Transaction Type
Venture Equity
Transaction Amount
$30,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds will be used to accelerate its two lead compounds — one a topical treatment for retinal diseases and the second a treatment for neurological diseases — while expanding its drug discovery and commercialization pipeline.
M&A Terms
Venture Investor
Venture Investor
Venture Investor